Atlas Trials

Empagliflozin and Hepatic Glucose Metabolism

Clinical trial NCT03193684 · COMPLETED

Trial details

NCT number
NCT03193684
Sponsor
The University of Texas Health Science Center at San Antonio
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatic Glucose Metabolism
Start date
2018-05-20
Primary completion
2023-01-30
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.